Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 2.84 M3.28 M3.11 M3.71 M3.65 M3.81 M 14.28 M Research & development —————— — Operating income 3.22 M2.1 M4.13 M1.88 M4.53 M3.7 M 14.24 M Non-Operating Income, Total -4.09 M-5.43 M9 M2.68 M-3.17 M83 K 8.6 M Interest expense, net of interest capitalized 4.5 M4.65 M4.56 M4.31 M4.21 M4.19 M 17.28 M Non-Operating Income, excl. Interest Expenses -4.03 M-3.45 M3.02 M-1.63 M-3.25 M-1.93 M -3.79 M Unusual income/expense 4.56 M-6.63 M1.42 M—-4.13 M-2.18 M — Pretax income 5.17 M1.83 M4.79 M-1.17 M6.05 M5.81 M 15.48 M Equity in earnings —————— — Taxes 102 K194 K52 K2 00070 K94 K 218 K Non-controlling/minority interest 504 K1.63 M-1.53 M1.13 M—— — After tax other income/expense —————— — Net income before discontinued operations -833 K-2.9 M4.01 M-4.11 M320 K1.23 M 1.46 M Discontinued operations —————— — Net income -833 K-2.9 M4.01 M-4.11 M320 K1.23 M 1.46 M Dilution adjustment ————-130 K-127 K — Preferred dividends ————239 K422 K — Diluted net income available to common stockholders -1.53 M-4.65 M5.41 M-7.5 M-49 K683 K -1.46 M Basic earnings per share (Basic EPS) -0.06-0.160.19-0.1900.03 0.03 Diluted earnings per share (Diluted EPS) -0.06-0.160.19-0.1900.03 0.03 Average basic shares outstanding 17.32 M19.14 M20.72 M19.76 M22.28 M22.83 M — Diluted shares outstanding 27.82 M27.83 M27.83 M27.84 M22.28 M23.11 M — EBITDA 10.93 M11.55 M11.46 M10.37 M12.2 M11.93 M 45.96 M EBIT 3.22 M2.1 M4.13 M1.88 M4.53 M3.7 M 14.24 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 7.71 M9.46 M7.33 M8.48 M7.67 M8.23 M 31.72 M